Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing a Physiology-Pharmacodynamic Model of Rocuronium Dose and Cardiac Output to Investigate the Onset Time of Neuromuscular Relaxation

NCT07168252 is registered in ClinicalTrials.gov with Clare Hayes-Bradley as lead sponsor.

NCT NCT07168252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07168252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing a Physiology-Pharmacodynamic Model of Rocuronium Dose and Cardiac Output to Investigate the Onset Time of Neuromuscular Relaxation
Lead sponsor
Clare Hayes-Bradley
Phase
Phase 4
Overall status
Not yet recruiting
Start date
December 1, 2025
Completion date
December 31, 2026
Enrollment
32 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

induction of anaesthesia, muscle relaxants, rocuronium